Aernoud T.L. Fiolet

3.4k total citations
42 papers, 647 citations indexed

About

Aernoud T.L. Fiolet is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Aernoud T.L. Fiolet has authored 42 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Immunology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Aernoud T.L. Fiolet's work include Inflammasome and immune disorders (18 papers), Atherosclerosis and Cardiovascular Diseases (12 papers) and Cardiovascular Disease and Adiposity (5 papers). Aernoud T.L. Fiolet is often cited by papers focused on Inflammasome and immune disorders (18 papers), Atherosclerosis and Cardiovascular Diseases (12 papers) and Cardiovascular Disease and Adiposity (5 papers). Aernoud T.L. Fiolet collaborates with scholars based in Netherlands, Australia and United States. Aernoud T.L. Fiolet's co-authors include Stefan M. Nidorf, Arend Mosterd, Jan H. Cornel, Tjerk S.J. Opstal, John W. Eikelboom, Jan G.P. Tijssen, Max J. M. Silvis, Dominique P.V. de Kleijn, Peter L. Thompson and Charley Budgeon and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Aernoud T.L. Fiolet

34 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aernoud T.L. Fiolet Netherlands	11	324	224	179	153	85	42	647
Juan Gómez Spain	19	418 1.3×	285 1.3×	392 2.2×	70 0.5×	110 1.3×	78	1.2k
Milana Ivkovic Denmark	3	117 0.4×	176 0.8×	125 0.7×	124 0.8×	112 1.3×	3	440
Kerstin Jurk Germany	12	126 0.4×	140 0.6×	171 1.0×	73 0.5×	115 1.4×	21	698
Hideaki Kimura Japan	16	112 0.3×	87 0.4×	130 0.7×	265 1.7×	257 3.0×	74	807
Catherine Fortier Canada	15	67 0.2×	136 0.6×	280 1.6×	99 0.6×	72 0.8×	46	792
Della Cole United Kingdom	10	92 0.3×	180 0.8×	209 1.2×	179 1.2×	85 1.0×	17	641
Kotaro Yokote Japan	8	60 0.2×	216 1.0×	162 0.9×	220 1.4×	111 1.3×	10	720
Stanislav Ignatenko Germany	9	122 0.4×	150 0.7×	87 0.5×	67 0.4×	42 0.5×	19	463
Jiaqian Qi China	13	265 0.8×	140 0.6×	42 0.2×	36 0.2×	45 0.5×	72	680
Bor‐Shen Hsieh Taiwan	17	189 0.6×	66 0.3×	107 0.6×	308 2.0×	45 0.5×	40	810

Countries citing papers authored by Aernoud T.L. Fiolet

Since Specialization

Citations

This map shows the geographic impact of Aernoud T.L. Fiolet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aernoud T.L. Fiolet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aernoud T.L. Fiolet more than expected).

Fields of papers citing papers by Aernoud T.L. Fiolet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aernoud T.L. Fiolet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aernoud T.L. Fiolet. The network helps show where Aernoud T.L. Fiolet may publish in the future.

Co-authorship network of co-authors of Aernoud T.L. Fiolet

This figure shows the co-authorship network connecting the top 25 collaborators of Aernoud T.L. Fiolet. A scholar is included among the top collaborators of Aernoud T.L. Fiolet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aernoud T.L. Fiolet. Aernoud T.L. Fiolet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poorthuis, Michiel H.F., et al.. (2026). Colchicine in Coronary Artery Disease: Comparative Review of CLEAR SYNERGY, LoDoCo2 and COLCOT. Current Atherosclerosis Reports. 28(1). 11–11.

Fiolet, Aernoud T.L., et al.. (2025). Current Evidence and Future Directions for Colchicine in the Prevention of Atherosclerotic Cardiovascular Disease. Thrombosis and Haemostasis.

Bax, Willem A., John W. Eikelboom, Arend Mosterd, et al.. (2025). Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohort. Atherosclerosis. 405. 119211–119211. 4 indexed citations

Fiolet, Aernoud T.L., Eric Boersma, Jan H. Cornel, et al.. (2025). Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease: The LoDoCo2 Trial. Journal of the American Heart Association. 14(5). e040412–e040412.

Fiolet, Aernoud T.L., Andrew Lin, Jacek Kwieciński, et al.. (2025). Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: a subanalysis of the LoDoCo2 trial. Heart. 111(23). 1156–1163.

Bax, Willem A., Stefan M. Nidorf, Arend Mosterd, et al.. (2025). Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial. Journal of the American Heart Association. 14(10). e038687–e038687.

Lalmohamed, Arief, Johan Zwaan, Toine C. G. Egberts, et al.. (2025). The effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists. European Journal of Clinical Pharmacology. 81(5). 719–725.

Fiolet, Aernoud T.L., Stefan M. Nidorf, John W. Eikelboom, et al.. (2024). Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands. European Heart Journal - Quality of Care and Clinical Outcomes. 11(1). 89–96. 2 indexed citations

Budgeon, Charley, Stefan M. Nidorf, Arend Mosterd, et al.. (2024). Exploration of the regional effects of colchicine in the LoDoCo2 trial. American Heart Journal. 278. 186–194. 1 indexed citations

10.

Poorthuis, Michiel H.F., Steven H J Hageman, Aernoud T.L. Fiolet, et al.. (2024). Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular Disease. Stroke. 55(11). 2632–2640. 2 indexed citations

11.

Fiolet, Aernoud T.L., Arend Mosterd, Jan G.P. Tijssen, et al.. (2023). Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements. Annals of Internal Medicine. 176(6). 737–742. 19 indexed citations

12.

Silvis, Max J. M., J. Los, Aernoud T.L. Fiolet, et al.. (2022). The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial. Clinical Drug Investigation. 42(11). 977–985. 13 indexed citations

13.

Jongh, Raf De, Marisa Ninivaggi, Aernoud T.L. Fiolet, et al.. (2022). Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98%. Frontiers in Immunology. 13. 977443–977443. 5 indexed citations

14.

Silvis, Max J. M., Gerardus P. J. van Hout, Aernoud T.L. Fiolet, et al.. (2021). Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned. BMC Cardiovascular Disorders. 21(1). 171–171. 8 indexed citations

15.

Fiolet, Aernoud T.L., et al.. (2020). Colchicine in coronary disease: another renaissance of an ancient drug. Cardiovascular Research. 117(1). e4–e6. 1 indexed citations

16.

Nidorf, Stefan M., Aernoud T.L. Fiolet, & George S. Abela. (2020). Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability. Journal of clinical lipidology. 14(5). 619–630. 42 indexed citations

17.

Nidorf, Stefan M., Aernoud T.L. Fiolet, John W. Eikelboom, et al.. (2019). The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics. American Heart Journal. 218. 46–56. 74 indexed citations

18.

Fiolet, Aernoud T.L., et al.. (2017). Malaria Fever Therapy for General Paralysis of the Insane: A Historical Cohort Study. European Neurology. 78(1-2). 56–62. 8 indexed citations

19.

Fiolet, Aernoud T.L., et al.. (2015). Clinical Presentation of General Paralysis of the Insane in a Dutch Psychiatric Hospital, 1924-1954. European Neurology. 74(1-2). 54–59. 5 indexed citations

20.

Koedijk, Femke D. H., Aernoud T.L. Fiolet, Maaike G. van Veen, et al.. (2013). Neurosyphilis in the mixed urban–rural community of the Netherlands. Acta Neuropsychiatrica. 26(3). 186–192. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact